Related Experiment Video
Updated: Sep 3, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently
Yujia Zheng1, Zheng Zhou1, Ran Wei2
1Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Background:
PolyC-RNA-binding protein 1 (PCBP1) functions as a tumour suppressor and RNA regulator that is downregulated in human cancers. Here, we aimed to reveal the biological function of PCBP1 in lung adenocarcinoma (LUAD).
Methods:
First, PCBP1 was identified as an important biomarker that maintains LUAD through The Cancer Genome Atlas (TCGA) project screening and confirmed by immunohistochemistry and qPCR. Via colony formation, CCK8, IncuCyte cell proliferation, wound healing and Transwell assays, we confirmed that PCBP1 was closely related to the proliferation and migration of LUAD cells. The downstream gene DKK1 was discovered by RNA sequencing of PCBP1 knockdown cells. The underlying mechanisms were further investigated using western blot, qPCR, RIP, RNA pulldown and mRNA stability assays.
Results:
We demonstrate that PCBP1 is downregulated in LUAD tumour tissues. The reduction in PCBP1 promotes the proliferation, migration and invasion of LUAD in vitro and in vivo. Mechanistically, the RNA-binding protein PCBP1 represses LUAD by stabilizing DKK1 mRNA. Subsequently, decreased expression of the DKK1 protein relieves the inhibitory effect on the Wnt/β-catenin signalling pathway. Taken together, these results show that PCBP1 acts as a tumour suppressor gene, inhibiting the tumorigenesis of LUAD.
Conclusions:
We found that PCBP1 inhibits LUAD development by upregulating DKK1 to inactivate the Wnt/β-catenin pathway. Our findings highlight the potential of PCBP1 as a promising therapeutic target.
Insights
PolyC-RNA-binding protein 1 (PCBP1) acts as a tumor suppressor in lung adenocarcinoma (LUAD). Downregulation of PCBP1 promotes LUAD cell proliferation and migration by stabilizing DKK1 mRNA, inactivating the Wnt/β-catenin pathway.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- PolyC-RNA-binding protein 1 (PCBP1) is a known tumor suppressor and RNA regulator.
- PCBP1 expression is frequently downregulated in various human cancers.
- The specific role of PCBP1 in lung adenocarcinoma (LUAD) requires further elucidation.
Purpose of the Study:
- To investigate the biological function and molecular mechanisms of PCBP1 in LUAD.
- To determine if PCBP1 acts as a tumor suppressor in LUAD.
- To identify downstream targets and pathways regulated by PCBP1 in LUAD.
Main Methods:
- Bioinformatic analysis using The Cancer Genome Atlas (TCGA) to identify PCBP1 as a LUAD biomarker.
- In vitro assays including colony formation, CCK8, cell proliferation, wound healing, and Transwell assays to assess cell behavior.
- RNA sequencing, western blot, qPCR, RIP, RNA pulldown, and mRNA stability assays to elucidate molecular mechanisms.
Main Results:
- PCBP1 is significantly downregulated in LUAD tissues.
- Reduced PCBP1 expression enhances LUAD cell proliferation, migration, and invasion in vitro and in vivo.
- PCBP1 directly binds to and stabilizes DKK1 mRNA, thereby repressing LUAD progression.
Conclusions:
- PCBP1 functions as a tumor suppressor in LUAD by upregulating DKK1 and consequently inhibiting the Wnt/β-catenin signaling pathway.
- PCBP1 downregulation promotes LUAD tumorigenesis.
- PCBP1 represents a potential therapeutic target for LUAD treatment.
Related Concept Videos
Inhibition of Cdk Activity
Canonical Wnt Signaling Pathway
Abnormal Proliferation
Negative Regulator Molecules
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
GPCRs Regulate Adenylyl Cylase Activity

